Matthew Shelley is an associate in Goodwin’s Technology and Life Sciences groups in London. Mr. Shelley advises clients on a broad range of corporate matters, with a focus on transactions in the life sciences, healthcare, and technology sectors. He has particular experience advising on private equity and venture capital investments/exits, mergers and acquisitions, corporate finance, and re-organizations as well as general corporate matters.

Areas of Practice
Domaines D’Expertise





  • Grip, an event networking app, on its $13 million Series A financing round led by Kennet Partners.
  • KaNDy Therapeutics, a private clinical-stage biotech, on its sale to Bayer for $425 million upfront with up to $450 million in development milestone payments and triple digit millions in commercial milestones.
  • Nodthera, a biotechnology company developing a new class of potent and selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation, on its $55 million Series B equity financing.
  • Omers Ventures, the London based venture capital arm of Canadian pension fund Omers, on its Series A investment into Quorso, a business analytics and performance platform.
  • Omers Ventures, as lead investor on its investment into FirstVet as part of a 18.5 million Series B financing round. FirstVet is a Swedish startup that provides pet owners with on-demand video consultations with local, qualified veterinarians.
  • CRV, as lead investor on its investment into GTMHUB, which provides software and services for organisational planning, as part of a $9 million Series A financing round.
  • Duffel, a travel distribution platform, on its $30 million Series B financing round which was led by Index Ventures and with participation from previous venture capital investors.
  • AGC Equity Partners on the sale of 25 Canada Square, currently the largest office building in the United Kingdom.*
  • Welsh, Carson, Anderson & Stowe, a leading US private equity firm focused primarily on technology and healthcare sectors, on the sale of its portfolio business AIM Software, a leading provider of data management solutions with a specialized focus on the buy-side, to SimCorp, a Danish listed entity, for an enterprise value of 60 million.*
  • HRA Pharma, a portfolio company of Astorg Partners, on the acquisition of the Mederma Brand from Merz Pharmaceuticals GmbH.*

* Denotes experience prior to joining Goodwin

In The News









Legal Practice Course, 2016
BPP Law School
Graduate Diploma in Law, 2015
BPP Law School
B.A., (2:1), Ancient History, 2014
University of Bristol, Bristol, UK



Solicitor of the Senior Courts of England and Wales
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique